(Q39378163)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426079%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426079%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426079%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Helene Blons

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426079%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Audrey Didelot

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426079%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Delphine Le Corre

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426079%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Armelle Luscan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426079%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Aurélie Cazes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426079%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Karine Pallier

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426079%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Jean-François Emile

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426079%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

7 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426079%20AND%20SRC:MED&resulttype=core&format=json

Experimental and Molecular Pathology

26 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426079%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426079%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426079%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

275-280

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22426079%20AND%20SRC:MED&resulttype=core&format=json

Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay

26 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.03.001

The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.03.001

BRAFV600E: implications for carcinogenesis and molecular therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.03.001

High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.03.001

Pyrosequencing, a method approved to detect the two major EGFR mutations for anti EGFR therapy in NSCLC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.03.001

Epidermal growth factor receptor gene mutation in non-small cell lung cancer using highly sensitive and fast TaqMan PCR assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.03.001

Targeted KRAS mutation assessment on patient tumor histologic material in real time diagnostics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.03.001

Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.03.001

Biotinylated probe isolation of targeted gene region improves detection of T790M epidermal growth factor receptor mutation via peptide nucleic acid-enriched real-time PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.03.001

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.03.001

Rapid detection of epidermal growth factor receptor mutations with multiplex PCR and primer extension in lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.03.001

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.03.001

Detection of mutations in EGFR in circulating lung-cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.03.001

Peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based detection test for gefitinib-refractory T790M epidermal growth factor receptor mutation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.03.001

Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: distinct natural history of patients with tumors harboring the T790M mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.03.001

Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.03.001

Benchmarking of mutation diagnostics in clinical lung cancer specimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.03.001

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.03.001

Targeting BRAF in advanced melanoma: a first step toward manageable disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.03.001

Quantifying EGFR alterations in the lung cancer genome with nanofluidic digital PCR arrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2012.03.001